• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS VITAMIN D ASSAY; VITAMIN D TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS VITAMIN D ASSAY; VITAMIN D TEST SYSTEM Back to Search Results
Model Number VITD TOTAL
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/23/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(6).
 
Event Description
The initial reporter stated they received discrepant results for two samples from the same patient tested with the elecsys vitamin d assay (vitd) and the elecsys vitamin d gen.2 assay (vitd2).Incorrect results for vitd and vitd2 were reported outside of the laboratory.This medwatch will apply to the vitd assay.Please refer to the medwatch with patient identifier (b)(6) for information related to vitd2.Refer to the attachment for all patient data.The samples were tested with vitd on the cobas 6000 e 601 module used at the customer site (e 601 #1).The samples were tested with vitd2 on a second e 601 analyzer (e 601 #2) used at a second site.The samples were also tested with vitd at a third site using an unknown roche analyzer.The e 601 analyzer used at the customer site (e 601 #1) is serial number (b)(4).The serial numbers of the other two analyzers were requested, but not provided.
 
Manufacturer Narrative
Refer to the attachment for updated information.Fields in yellow have been updated.The 216 nmol/l value in row 2 of the table is actually the final calculated value for the last (b)(6) 2019 measurement of sample 1 (108.2 nmol/l after x2 manual dilution).The serial numbers of the other two analyzers at the third site were provided as (b)(6).Medwatch fields a3 and b3 has been updated.The patient is a clinician and believed the vitd2 results to be clinically correct as she does not have the possibility of vitamin d toxicosis.- attachment: [pt-42560_pt-42561.Pdf].
 
Manufacturer Narrative
Based on the provided information and data, the observed differences can be explained as follows: vitd2 has low cross reactivity to vitamin d metabolites, compared to vitd.Therefore, cross reactivity of the sample to the vitd assay is possible.Different assay standardizations can contribute to a different recovery of higher concentrated samples.Vitamin d derivatives in the sample may be recognized by the vitd assay, but these same derivatives may have reduced recognition or may not be recognized with the vitd2 assay.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS VITAMIN D ASSAY
Type of Device
VITAMIN D TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9546565
MDR Text Key199260458
Report Number1823260-2020-00028
Device Sequence Number1
Product Code MRG
Combination Product (y/n)N
PMA/PMN Number
K113546
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 04/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/03/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Model NumberVITD TOTAL
Device Catalogue Number05894913190
Device Lot Number43548302
Was Device Available for Evaluation? Yes
Date Manufacturer Received12/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-